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Background: To determine the median effective concentration of sufentanil as an analgesic during wake-up tests
after sevoflurane anesthesia during surgery for adolescent idiopathic scoliosis (AIS).
Methods: This is a randomised controlled trial. Sixty patients aged 13–18 years scheduled for AIS surgery were
randomized into six groups of 10 patients each to receive target effect-site concentrations of sufentanil of 0.19,
0.1809, 0.1723, 0.1641, 0.1563, and 0.1489 ng/ml (target concentration ratio, 1.05). Wake-up time was recorded.
Median EC50 and 95% confidence interval (CI) for sufentanil target-controlled infusion (TCI) were determined
using Kärber’s method. The primary outcome was median EC50 for sufentanil TCI as an analgesic during the
wake-up test after sevoflurane anesthesia during surgery for AIS.
Results: The EC50 and 95% CI of sufentanil TCI were 0.1682 ng/ml and 0.1641 ~ 0.1724 ng/ml, respectively.
Conclusions: The EC50 of sufentanil TCI was 0.1682 ng/ml (95% CI: 0.1641 ~ 0.1724 ng/ml) during sevoflurane
anesthesia in adolescents undergoing surgery for idiopathic scoliosis with intraoperative wake-up tests.
Trial registration: Clinicaltrials.gov identifier: ChiCTR-TTRCC-12002696.
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Adolescent idiopathic scoliosis (AIS) is one of the most
common structural spinal deformities in the coronal plane
affecting young people. Depending on severity, treatment
consists mainly of observation, braces and surgical correc-
tion [1], with surgical correction required only when the
deformity is greater than 40° [2]. The most important
neurological complication during surgery for AIS is iatro-
genic spinal cord injury. The wake-up test is the standard
neurophysiological procedure for the intraoperative detec-
tion of emerging spinal cord injuries during the surgical
correction of AIS [3]. In addition to faster recovery of con-
sciousness from anesthesia, the wake-up test is accompan-
ied by several adverse phenomena, including coughing,
agitation, hypertension, and tachycardia [4]. Thus, during
surgery for AIS, the anesthesiologist must balance* Correspondence: 572155713@qq.com
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unless otherwise stated.adequate sedation and analgesia to prevent bad mem-
ories as a result of postoperative recall and sufficient
consciousness to respond to commands [5].
Recent reports have indicated that target-controlled infu-
sion (TCI) of sufentanil is more useful for achieving analgesia
and preventing cough and agitation [6] than remifenta-
nil, a short-action opioid [7,8] during anesthesia. Balanced
anesthesia is usually achieved by the coadministration of
sufentanil, a long-acting opioid, and sevoflurane [9], with
the two agents acting synergetically to reduce the adverse
effects of each as a single agent.
To our knowledge, however, no study has investigated
the median effective concentration of sufentanil as an anal-
gesic during the wake-up test after sevoflurane anesthesia
during surgery for AIS. We therefore determined the me-
dian effective concentration of sufentanil required to pro-
vide excellent analgesic effects in these patients after
sevoflurane anesthesia.This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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Following approval by the ethics committee of Kunming
General Hospital of the Chengdu Military Area (Trial
registration number: ChiCTR-TTRCC-12002696) and
written, informed consent from the patients and their
parents, we enrolled consecutive ASA physical status I
patients, aged 13–18 years, scheduled to undergo sur-
gery for AIS. Sixty patients in this double-blinded
study were randomized to 6 groups (n = 10) according
to a table of random numbers, since 5 ~ 20 patients
per group are thought sufficient for the Behrens-
Kärber method. The target effect-site concentration of
each group during wake-up tests was defined as the
preliminary result; beginning with 0.19 ng/ml, the con-
centration ratio was 1.05. Exclusion criteria included
history of neurological, cardiac or pulmonary disease,
any central nervous system disease, long-term admin-
istration of sedatives or a history of alcohol abuse. The
day before surgery, all enrolled patients received de-
tailed instructions about the wake-up test.
Anesthetic preparation
Perioperative monitoring included 5-lead electrocardio-
gram (ECG), pulse oxygen saturation (SpO2), heart rate
(HR), central venous pressure (CVP), and invasive blood
pressure (mean artery pressure, MAP). A bispectral index
(BIS) monitor (BIS-XP monitor, Aspect Medical Systems
Inc., Norwood, MA, USA) was applied to each patient.
Muscle relaxation level was monitored with TOF-Watch®
SX (Organon, The Netherlands).
The TCI pump administered a target effect-site concen-
trations of sufentanil (sufentanil Gepts model) based on
t1/2, Keo and patient age. Before induction of anesthesia,
the TCI of sufentanil as a co-adjuvant analgesic was
started with a target Ce of 0.5 ng/ml, based on a prelimin-
ary experiment, and intravenous etomidate was adminis-
trated at a dose of 0.15 ~ 0.3 mg/kg. Once the patient lost
consciousness, cisatracurium besylate 0.15 mg/kg was ad-
ministered iv as a muscle relaxant. Thereafter, the trachea
was intubated and the lungs were mechanically ventilated.
Expired concentrations of sevoflurane, carbon dioxide
(CO2), and oxygen were measured continuously using the
anesthesia workstation (Zeus®Infinity Empowered, Drager
Medical, Lubeck, Germany), with the end-tidal concentra-
tion of sevoflurane maintained between 0.8%~ 1.5% and end
tidal CO2 between 30 ~ 40 mmHg (1 mmHg= 0.133 kPa).
Paralysis was maintained with a continuous infusion of
cisatracurium besylate 0.1 mg/kg/h and a TCI of sufen-
tanil (0.2 ~ 0.3 ng/ml) using a TCI-III pump (Orchestra®
Base Primea, Fresenius Vial, France). Sufentanil dose was
based on a preliminary test. Adequate anesthesia was de-
fined as a BIS value between 40 and 55 and maintenance
of HR and MAP without exceeding 20% of the baseline
value.Wake-up test
During this period, no cisatracurium besylate was injected,
infusion pumps were stopped, the end-tidal concentration
of sevoflurane was 0, and the target concentrations of
sufentanil in all groups were down-regulated to the target
effect-site concentrations of 0.19, 0.1809, 0.1723, 0.1641,
0.1563, and 0.1489 ng/ml (target concentration ratio 1.05).
Five minutes later, the patient’s name was repeated every
15 seconds, followed by a request to move both feet. If the
patients did not respond to command within 15 min, the
TCI of sufentanil was stopped until the patients responded.
When the wake-up test was completed, cisatracurium
besylate 0.03 mg/kg was administrated i.v. and the infusion
pump was restarted. The lungs were ventilated again and
anesthesia was maintained in each group as before. Within
24 hours after surgery, vital signs, consciousness and intra-
operative awareness were determined in all patients once
every 4 hours.
The patient’s name was repeated every 15 seconds,
followed by a request to move both feet. Success was de-
fined as a response to command within 15 min. The
numbers of successful cases (r) were recorded in each
group and the logarithm of target effect-site concentra-
tion (x), success (p) and failure (q) rates of the wake-up
test (p), the logarithm of maximum target effect con-
centration (xm) and the difference in the logarithm of
adjacent concentrations (i) were calculated. The data
were also evaluated according to the Behrens-Kärber
method [10].
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Statistics
Statistical analysis was performed using SPSS 17.0 for
Windows. Data are expressed as means ± sd and ana-
lyzed using one-way ANOVA. Categorical data were
expressed as the number of patients (%) and analyzed
using the χ2 test. A P-value <0.05 was considered statisti-
cally significant.
Results
Sixty patients successfully completed the study. The 6
patient groups were similar in age, body mass index
(BMI), gender and ASA distribution (Table 1). Duration
from induction of anesthesia to start of the wake-up test
did not differ significantly among the patient groups.
Two patients had adverse reactions during operation,
with one having hypertension and tachycardia and one
Table 1 Characteristics of patient groups
Group Sex (M/F) Age (year) BMI (kg/m2) Anesthesia duration
before wake up (min)
1 5/5 15 ± 3 21 ± 2 235 ± 36
2 6/4 14 ± 3 22 ± 2 228 ± 44
3 4/6 14 ± 4 22 ± 2 241 ± 34
4 4/6 15 ± 3 21 ± 3 246 ± 30
5 5/5 15 ± 3 22 ± 2 239 ± 38
6 6/4 14 ± 3 21 ± 2 242 ± 37
n = 10 per group. Results reported as mean ± sd.
Zhang et al. BMC Anesthesiology  (2015) 15:27 Page 3 of 4having cough/restless reaction. None of these patients
experienced bad memories.
The sufentanil EC50 as an analgesic during sevoflur-
ane anesthesia was 0.1682 ng/ml (95% CI, 0.1641 ~
0.1724 ng/ml) (Table 2).
Discussion
Neurologic deficits may be caused directly by surgery for
AIS [11]. Once complete spinal cord damage has oc-
curred, the likelihood of recovery is limited. Use of intra-
operative wake-up tests may decrease the incidence of
over- or undercorrection, preventing the progression of
spinal cord injury [12]. During the wake-up procedure,
the depth of anesthesia should be lightened so that pa-
tients respond to the surgeon’s verbal commands. Recov-
ery of awareness, however, may be accompanied by
coughing and agitation resulting from the operation it-
self. Although sufentanil is an analgesic, not a hypnotic,
it has been found to affect opioid receptors in the limbic
system, eliminating the emotional reactions induced by
pain, such as anxiety, tension, and inability to easily fall
asleep. Sufentanil may dose-dependently enhance the in-
hibitory effect of sevoflurane on the CNS, with a high
concentration of sufentanil affecting awakening speed
and enhancing the effect of anesthetics [13]. TCI sufen-
tanil model parameters have been validated for this pa-
tient population [14]. Sufentanil has been found to result
in better analgesia and more stable hemodynamics [15],
and the combination of sufentanil and the inhaled anesthetic
sevoflurane has been found to produce synergistic effects inTable 2 Success and failure rate in each group and EC50 (95%
Group Target effect-site concentration
of sufentanil (ng/ml)








95%CI: 95% confidence interval.the induction of anesthesia [16].Sufentanil has been found
to improve the quality of awakening [15] and to reduce
the likelihood of postoperative complications [17]. Of
our 60 patients, none recalled intraoperative pain or
other events after the wake-up test, a result likely due
to their treatment with combined anesthesia (sevoflur-
ane and sufentanil) rather than one drug [18].
Ideally, adequate analgesia should be accompanied by
a lack of effect on the recovery of consciousness. To
minimize the effect-site concentration of sufentanil
under the wake-up test during surgery for AIS, we de-
creased the end-tidal concentration of sevoflurane to 0
to eliminate the effect of sevoflurane on the faster recov-
ery of consciousness [19] and calculated the median ef-
fective concentration of sufentanil by the Behrens-Kärber
method. Our preliminary results indicated that patients
did not respond to command when the target effect-site
concentration was 0.19 ng/ml, but did respond when
the target effect-site concentration was 0.14 ng/ml.
Therefore, using the Behrens-Kärber method, the six
indicated effect site concentrations were chosen. We
found that the minimum effect-site concentration of
sufentanil was 0.14 ng/ml and the EC50 of sufentanil
TCI was 0.1682 ng/ml (95% CI: 0.1641 ~ 0.1724 ng/ml).
Induction of anesthesia with a combination of sevoflurane
and sufentanil may improve the success rate of intraopera-
tive wake-up tests. These tests should measure both the
appropriate depth of sedation analgesia that effectively in-
hibits nociceptive stimuli caused by stress and the rate of
successful awakening. A higher effect-site concentration
of sufentanil, within its appropriate range, may inhibit
stress responses induced by nociceptive stimuli such as
the insertion of an endotracheal tube and surgical incision,
due to a stronger analgesic effect. Higher doses, outside
the appropriate range, may cause delay or failure of wake-
up tests, whereas doses lower than the appropriate range
may result in stronger stress responses. We observed a
sufentanil EC50 of 0.1682 ng/ml, making the lower limit of
the appropriate range 0.14 ng/ml, a concentration provid-
ing a reference for appropriate depth of clinical analgesia.
A major shortcoming of this study was our lack of
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effect-site concentrations, plasma concentrations and
clinical indicators, including blood pressure, heart rate
and BIS [20,21]. Therefore, any errors due to interindi-
vidual variability and differences between target effect-
site concentrations and plasma concentrations were
likely negligible.
Conclusion
In conclusion, we found that the inhalation of sevoflur-
ane combined with sufentanil TCI resulted in uncompli-
cated induction of anesthesia. Furthermore, we showed
that the EC50 of the sufentanil effect-site concentration
for analgesia during sevoflurane anesthesia in surgery for
AIS with an intraoperative wake-up test was 0.1682 ng/ml
(95% CI, 0.1641 ~ 0.1724 ng/ml). Anesthesia induction
with the combination of sevoflurane and sufentanil may
improve the success rate of intraoperative wake-up tests.
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